COMMUNIQUÉS West-GlobeNewswire

Fort Worth Plastic Surgeon Jon Kurkjian, MD Earns Esteemed RealSelf 100 Award
22/05/2018
Dr. Jon Kurkjian was recognized as one of the most engaging, helpful, and respected aesthetic practitioners on RealSelf. FORT WORTH, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- Jon Kurkjian, MD, a plastic surgeon in Fort [...]
Alberta’s Top Business Leaders Announced for 2018 CEO Rescue in the Rockies for STARS
22/05/2018
Prominent Alberta-based CEOs will be airlifted into the wilderness for annual fundraiser CALGARY, Alberta, May 22, 2018 (GLOBE NEWSWIRE) -- The Shock Trauma Air Rescue Service (STARS), a non-profit helicopter air [...]
Medecision Acquires Transformational Change Firm, Aveus
22/05/2018
Helps Medecision’s clients assess and accelerate population health strategies and outcomes DALLAS and MINNEAPOLIS, May 22, 2018 (GLOBE NEWSWIRE) -- Medecision , a leader in population health management solutions, [...]
Progyny Named to the 2018 CNBC Disruptor 50 List
22/05/2018
The fertility benefits management company placed #15 and for the second year in a row is among 50 companies that collectively have the potential to upend multibillion-dollar industries NEW YORK, May 22, 2018 (GLOBE [...]
CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California
22/05/2018
LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp extract products, PlusCBD [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - FIT Biotech's own equity positive with draw down of fourth Tranche
22/05/2018
FIT Biotech Oy Company release May 22, 2018 at 3:30 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants - FIT Biotech's own equity positive with draw down of fourth [...]
Ritter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP-G28 for Lactose Intolerance
22/05/2018
LOS ANGELES, May 22, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]
Yield10 Bioscience Exercises Option with University of Missouri to Obtain Exclusive Worldwide License to Advanced Technologies for Oilseed Crops
22/05/2018
WOBURN, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]
Zosano Appoints Steven A. Elms to Board of Directors
22/05/2018
FREMONT, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Progenics Announces JAMA Oncology Publication Highlighting Company’s Imaging Analysis Platform
22/05/2018
Data Support Prognostic Utility of aBSI as an Imaging Biomarker for Survival in Patients with Castration-Resistant Prostate Cancer NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX [...]
Oxford Immunotec Announces Launch of the Accutix™ Brand
22/05/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 22, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced the launch of the Accutix brand for [...]
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
22/05/2018
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced it has closed its previously announced $50 million registered direct offering of newly designated [...]
Novo Nordisk A/S - Share repurchase programme
22/05/2018
Bagsværd, Denmark, 22 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]
Kane Biotech Appoints Pharmaceutical Executive Rashieda Gluck to Board of Directors
22/05/2018
WINNIPEG, Manitoba, May 22, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce it has appointed Rashieda (Rivka) Gluck to the Corporation [...]
Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event
22/05/2018
NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, is proud to sponsor A Cure In Sight [...]
Share buy-back week 20/2018
22/05/2018
Announcement 22 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes
22/05/2018
BRIDGEWATER, N.J. and THE WOODLANDS, Texas, May 22, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) has accepted Sanofi’s regulatory filing for Zynquista (sotagliflozin). The investigational oral [...]
Cognition Therapeutics Receives $6.6M in NIA Grants for Two Studies of Elayta™ to Expand Understanding of Synaptoprotective Mechanism of Action
22/05/2018
PITTSBURGH, May 22, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]
Innovate Biopharmaceuticals Scheduled to Present at BIO 2018 Convention in Boston on Tuesday, June 5, 2018, at 4:45PM
22/05/2018
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]

Pages